nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosutinib—LRRK2—Alzheimer's disease	0.269	0.5	CbGaD
Bosutinib—PTK2B—Alzheimer's disease	0.269	0.5	CbGaD
Bosutinib—Lipase increased—Rivastigmine—Alzheimer's disease	0.00279	0.0238	CcSEcCtD
Bosutinib—Drug hypersensitivity—Memantine—Alzheimer's disease	0.00208	0.0177	CcSEcCtD
Bosutinib—Electrocardiogram QT prolonged—Galantamine—Alzheimer's disease	0.00186	0.0158	CcSEcCtD
Bosutinib—Pancreatitis acute—Memantine—Alzheimer's disease	0.00182	0.0155	CcSEcCtD
Bosutinib—Amylase increased—Rivastigmine—Alzheimer's disease	0.00172	0.0147	CcSEcCtD
Bosutinib—Blood creatine phosphokinase increased—Donepezil—Alzheimer's disease	0.00134	0.0114	CcSEcCtD
Bosutinib—Electrocardiogram QT prolonged—Memantine—Alzheimer's disease	0.00131	0.0111	CcSEcCtD
Bosutinib—Electrocardiogram QT prolonged—Rivastigmine—Alzheimer's disease	0.00128	0.0109	CcSEcCtD
Bosutinib—Blood creatine phosphokinase increased—Rivastigmine—Alzheimer's disease	0.00119	0.0102	CcSEcCtD
Bosutinib—Pleural effusion—Rivastigmine—Alzheimer's disease	0.00107	0.00912	CcSEcCtD
Bosutinib—Gamma-glutamyltransferase increased—Memantine—Alzheimer's disease	0.00102	0.00868	CcSEcCtD
Bosutinib—Vandetanib—VEGFA—Alzheimer's disease	0.000947	0.745	CrCbGaD
Bosutinib—Renal impairment—Galantamine—Alzheimer's disease	0.000909	0.00774	CcSEcCtD
Bosutinib—Respiratory failure—Memantine—Alzheimer's disease	0.000854	0.00727	CcSEcCtD
Bosutinib—Respiratory failure—Rivastigmine—Alzheimer's disease	0.000835	0.00712	CcSEcCtD
Bosutinib—Hyperkalaemia—Memantine—Alzheimer's disease	0.000824	0.00702	CcSEcCtD
Bosutinib—Dehydration—Galantamine—Alzheimer's disease	0.000804	0.00685	CcSEcCtD
Bosutinib—Abdominal pain upper—Galantamine—Alzheimer's disease	0.00079	0.00673	CcSEcCtD
Bosutinib—Fluid retention—Rivastigmine—Alzheimer's disease	0.000779	0.00663	CcSEcCtD
Bosutinib—Gastritis—Galantamine—Alzheimer's disease	0.000765	0.00652	CcSEcCtD
Bosutinib—Rash maculo-papular—Rivastigmine—Alzheimer's disease	0.000745	0.00635	CcSEcCtD
Bosutinib—Bronchitis—Galantamine—Alzheimer's disease	0.000719	0.00612	CcSEcCtD
Bosutinib—Abdominal discomfort—Galantamine—Alzheimer's disease	0.000717	0.0061	CcSEcCtD
Bosutinib—Hepatic function abnormal—Memantine—Alzheimer's disease	0.000696	0.00593	CcSEcCtD
Bosutinib—Upper respiratory tract infection—Galantamine—Alzheimer's disease	0.000695	0.00592	CcSEcCtD
Bosutinib—Pneumonia—Galantamine—Alzheimer's disease	0.00067	0.00571	CcSEcCtD
Bosutinib—Gastrointestinal haemorrhage—Donepezil—Alzheimer's disease	0.00067	0.00571	CcSEcCtD
Bosutinib—Renal failure acute—Memantine—Alzheimer's disease	0.000659	0.00562	CcSEcCtD
Bosutinib—Renal failure—Galantamine—Alzheimer's disease	0.000655	0.00558	CcSEcCtD
Bosutinib—Face oedema—Donepezil—Alzheimer's disease	0.000647	0.00551	CcSEcCtD
Bosutinib—Renal failure acute—Rivastigmine—Alzheimer's disease	0.000645	0.00549	CcSEcCtD
Bosutinib—Renal impairment—Memantine—Alzheimer's disease	0.000639	0.00545	CcSEcCtD
Bosutinib—Hepatobiliary disease—Galantamine—Alzheimer's disease	0.00063	0.00537	CcSEcCtD
Bosutinib—Blood creatinine increased—Donepezil—Alzheimer's disease	0.000628	0.00535	CcSEcCtD
Bosutinib—Renal impairment—Rivastigmine—Alzheimer's disease	0.000626	0.00533	CcSEcCtD
Bosutinib—Dehydration—Donepezil—Alzheimer's disease	0.000623	0.00531	CcSEcCtD
Bosutinib—Abdominal pain upper—Donepezil—Alzheimer's disease	0.000612	0.00522	CcSEcCtD
Bosutinib—Gastrointestinal haemorrhage—Memantine—Alzheimer's disease	0.000609	0.00518	CcSEcCtD
Bosutinib—Aspartate aminotransferase increased—Donepezil—Alzheimer's disease	0.000604	0.00514	CcSEcCtD
Bosutinib—Nasopharyngitis—Donepezil—Alzheimer's disease	0.000599	0.00511	CcSEcCtD
Bosutinib—Hepatitis—Galantamine—Alzheimer's disease	0.000598	0.0051	CcSEcCtD
Bosutinib—Gastrointestinal haemorrhage—Rivastigmine—Alzheimer's disease	0.000595	0.00507	CcSEcCtD
Bosutinib—Gastritis—Donepezil—Alzheimer's disease	0.000593	0.00505	CcSEcCtD
Bosutinib—Alanine aminotransferase increased—Donepezil—Alzheimer's disease	0.000591	0.00504	CcSEcCtD
Bosutinib—Urinary tract disorder—Galantamine—Alzheimer's disease	0.000591	0.00503	CcSEcCtD
Bosutinib—Oedema peripheral—Galantamine—Alzheimer's disease	0.000589	0.00502	CcSEcCtD
Bosutinib—Connective tissue disorder—Galantamine—Alzheimer's disease	0.000588	0.00501	CcSEcCtD
Bosutinib—Urethral disorder—Galantamine—Alzheimer's disease	0.000587	0.005	CcSEcCtD
Bosutinib—Influenza—Donepezil—Alzheimer's disease	0.000579	0.00494	CcSEcCtD
Bosutinib—Face oedema—Rivastigmine—Alzheimer's disease	0.000575	0.0049	CcSEcCtD
Bosutinib—Blood creatinine increased—Memantine—Alzheimer's disease	0.00057	0.00486	CcSEcCtD
Bosutinib—Dehydration—Memantine—Alzheimer's disease	0.000566	0.00482	CcSEcCtD
Bosutinib—Tinnitus—Galantamine—Alzheimer's disease	0.000558	0.00475	CcSEcCtD
Bosutinib—Bronchitis—Donepezil—Alzheimer's disease	0.000557	0.00475	CcSEcCtD
Bosutinib—Abdominal discomfort—Donepezil—Alzheimer's disease	0.000555	0.00473	CcSEcCtD
Bosutinib—Cardiac disorder—Galantamine—Alzheimer's disease	0.000555	0.00473	CcSEcCtD
Bosutinib—Dehydration—Rivastigmine—Alzheimer's disease	0.000554	0.00472	CcSEcCtD
Bosutinib—Aspartate aminotransferase increased—Memantine—Alzheimer's disease	0.000548	0.00467	CcSEcCtD
Bosutinib—Nasopharyngitis—Memantine—Alzheimer's disease	0.000544	0.00464	CcSEcCtD
Bosutinib—Abdominal pain upper—Rivastigmine—Alzheimer's disease	0.000544	0.00463	CcSEcCtD
Bosutinib—Immune system disorder—Galantamine—Alzheimer's disease	0.00054	0.0046	CcSEcCtD
Bosutinib—Gastritis—Memantine—Alzheimer's disease	0.000539	0.00459	CcSEcCtD
Bosutinib—Alanine aminotransferase increased—Memantine—Alzheimer's disease	0.000537	0.00457	CcSEcCtD
Bosutinib—Nasopharyngitis—Rivastigmine—Alzheimer's disease	0.000532	0.00454	CcSEcCtD
Bosutinib—Gastritis—Rivastigmine—Alzheimer's disease	0.000527	0.00449	CcSEcCtD
Bosutinib—Influenza—Memantine—Alzheimer's disease	0.000526	0.00448	CcSEcCtD
Bosutinib—Malnutrition—Galantamine—Alzheimer's disease	0.000521	0.00444	CcSEcCtD
Bosutinib—Pneumonia—Donepezil—Alzheimer's disease	0.00052	0.00443	CcSEcCtD
Bosutinib—Infestation—Donepezil—Alzheimer's disease	0.000517	0.0044	CcSEcCtD
Bosutinib—Infestation NOS—Donepezil—Alzheimer's disease	0.000517	0.0044	CcSEcCtD
Bosutinib—Dysgeusia—Galantamine—Alzheimer's disease	0.00051	0.00435	CcSEcCtD
Bosutinib—Renal failure—Donepezil—Alzheimer's disease	0.000508	0.00433	CcSEcCtD
Bosutinib—Bronchitis—Memantine—Alzheimer's disease	0.000506	0.00431	CcSEcCtD
Bosutinib—Back pain—Galantamine—Alzheimer's disease	0.000504	0.00429	CcSEcCtD
Bosutinib—Pancytopenia—Memantine—Alzheimer's disease	0.0005	0.00426	CcSEcCtD
Bosutinib—Bronchitis—Rivastigmine—Alzheimer's disease	0.000495	0.00422	CcSEcCtD
Bosutinib—Neutropenia—Memantine—Alzheimer's disease	0.000492	0.00419	CcSEcCtD
Bosutinib—Upper respiratory tract infection—Memantine—Alzheimer's disease	0.000489	0.00416	CcSEcCtD
Bosutinib—Ill-defined disorder—Galantamine—Alzheimer's disease	0.000483	0.00412	CcSEcCtD
Bosutinib—Anaemia—Galantamine—Alzheimer's disease	0.000481	0.0041	CcSEcCtD
Bosutinib—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.000478	0.00407	CcSEcCtD
Bosutinib—Pneumonia—Memantine—Alzheimer's disease	0.000472	0.00402	CcSEcCtD
Bosutinib—Malaise—Galantamine—Alzheimer's disease	0.00047	0.004	CcSEcCtD
Bosutinib—Infestation NOS—Memantine—Alzheimer's disease	0.000469	0.004	CcSEcCtD
Bosutinib—Infestation—Memantine—Alzheimer's disease	0.000469	0.004	CcSEcCtD
Bosutinib—Hepatitis—Donepezil—Alzheimer's disease	0.000464	0.00395	CcSEcCtD
Bosutinib—Pneumonia—Rivastigmine—Alzheimer's disease	0.000461	0.00393	CcSEcCtD
Bosutinib—Renal failure—Memantine—Alzheimer's disease	0.000461	0.00393	CcSEcCtD
Bosutinib—Infestation NOS—Rivastigmine—Alzheimer's disease	0.000459	0.00391	CcSEcCtD
Bosutinib—Infestation—Rivastigmine—Alzheimer's disease	0.000459	0.00391	CcSEcCtD
Bosutinib—Urinary tract disorder—Donepezil—Alzheimer's disease	0.000458	0.0039	CcSEcCtD
Bosutinib—Oedema peripheral—Donepezil—Alzheimer's disease	0.000457	0.00389	CcSEcCtD
Bosutinib—Urethral disorder—Donepezil—Alzheimer's disease	0.000455	0.00387	CcSEcCtD
Bosutinib—Cough—Galantamine—Alzheimer's disease	0.000454	0.00387	CcSEcCtD
Bosutinib—Renal failure—Rivastigmine—Alzheimer's disease	0.000451	0.00384	CcSEcCtD
Bosutinib—Hepatobiliary disease—Memantine—Alzheimer's disease	0.000444	0.00378	CcSEcCtD
Bosutinib—Myalgia—Galantamine—Alzheimer's disease	0.000443	0.00378	CcSEcCtD
Bosutinib—Arthralgia—Galantamine—Alzheimer's disease	0.000443	0.00378	CcSEcCtD
Bosutinib—Chest pain—Galantamine—Alzheimer's disease	0.000443	0.00378	CcSEcCtD
Bosutinib—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00044	0.00375	CcSEcCtD
Bosutinib—Discomfort—Galantamine—Alzheimer's disease	0.000438	0.00373	CcSEcCtD
Bosutinib—Agranulocytosis—Memantine—Alzheimer's disease	0.000438	0.00373	CcSEcCtD
Bosutinib—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.000434	0.0037	CcSEcCtD
Bosutinib—Tinnitus—Donepezil—Alzheimer's disease	0.000432	0.00368	CcSEcCtD
Bosutinib—Hepatitis—Memantine—Alzheimer's disease	0.000421	0.00359	CcSEcCtD
Bosutinib—Nervous system disorder—Galantamine—Alzheimer's disease	0.000417	0.00355	CcSEcCtD
Bosutinib—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000416	0.00355	CcSEcCtD
Bosutinib—Urinary tract disorder—Memantine—Alzheimer's disease	0.000416	0.00354	CcSEcCtD
Bosutinib—Oedema peripheral—Memantine—Alzheimer's disease	0.000415	0.00353	CcSEcCtD
Bosutinib—Connective tissue disorder—Memantine—Alzheimer's disease	0.000414	0.00352	CcSEcCtD
Bosutinib—Skin disorder—Galantamine—Alzheimer's disease	0.000413	0.00352	CcSEcCtD
Bosutinib—Urethral disorder—Memantine—Alzheimer's disease	0.000413	0.00352	CcSEcCtD
Bosutinib—Hepatitis—Rivastigmine—Alzheimer's disease	0.000412	0.00351	CcSEcCtD
Bosutinib—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000407	0.00347	CcSEcCtD
Bosutinib—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000406	0.00346	CcSEcCtD
Bosutinib—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000405	0.00345	CcSEcCtD
Bosutinib—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000404	0.00344	CcSEcCtD
Bosutinib—Malnutrition—Donepezil—Alzheimer's disease	0.000404	0.00344	CcSEcCtD
Bosutinib—Erythema multiforme—Memantine—Alzheimer's disease	0.000398	0.00339	CcSEcCtD
Bosutinib—Dysgeusia—Donepezil—Alzheimer's disease	0.000395	0.00337	CcSEcCtD
Bosutinib—Tinnitus—Memantine—Alzheimer's disease	0.000393	0.00334	CcSEcCtD
Bosutinib—Cardiac disorder—Memantine—Alzheimer's disease	0.000391	0.00333	CcSEcCtD
Bosutinib—Back pain—Donepezil—Alzheimer's disease	0.00039	0.00333	CcSEcCtD
Bosutinib—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000389	0.00332	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000387	0.0033	CcSEcCtD
Bosutinib—Tinnitus—Rivastigmine—Alzheimer's disease	0.000384	0.00327	CcSEcCtD
Bosutinib—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000382	0.00326	CcSEcCtD
Bosutinib—Immune system disorder—Memantine—Alzheimer's disease	0.00038	0.00324	CcSEcCtD
Bosutinib—Mediastinal disorder—Memantine—Alzheimer's disease	0.000379	0.00323	CcSEcCtD
Bosutinib—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000375	0.00319	CcSEcCtD
Bosutinib—Anaemia—Donepezil—Alzheimer's disease	0.000373	0.00318	CcSEcCtD
Bosutinib—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000371	0.00316	CcSEcCtD
Bosutinib—Decreased appetite—Galantamine—Alzheimer's disease	0.00037	0.00315	CcSEcCtD
Bosutinib—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000367	0.00313	CcSEcCtD
Bosutinib—Malnutrition—Memantine—Alzheimer's disease	0.000366	0.00312	CcSEcCtD
Bosutinib—Fatigue—Galantamine—Alzheimer's disease	0.000366	0.00312	CcSEcCtD
Bosutinib—Malaise—Donepezil—Alzheimer's disease	0.000364	0.0031	CcSEcCtD
Bosutinib—Dysgeusia—Memantine—Alzheimer's disease	0.000359	0.00306	CcSEcCtD
Bosutinib—Malnutrition—Rivastigmine—Alzheimer's disease	0.000359	0.00305	CcSEcCtD
Bosutinib—Back pain—Memantine—Alzheimer's disease	0.000355	0.00302	CcSEcCtD
Bosutinib—Cough—Donepezil—Alzheimer's disease	0.000352	0.003	CcSEcCtD
Bosutinib—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000351	0.00299	CcSEcCtD
Bosutinib—Feeling abnormal—Galantamine—Alzheimer's disease	0.00035	0.00298	CcSEcCtD
Bosutinib—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000348	0.00296	CcSEcCtD
Bosutinib—Back pain—Rivastigmine—Alzheimer's disease	0.000347	0.00295	CcSEcCtD
Bosutinib—Chest pain—Donepezil—Alzheimer's disease	0.000344	0.00293	CcSEcCtD
Bosutinib—Myalgia—Donepezil—Alzheimer's disease	0.000344	0.00293	CcSEcCtD
Bosutinib—Arthralgia—Donepezil—Alzheimer's disease	0.000344	0.00293	CcSEcCtD
Bosutinib—Ill-defined disorder—Memantine—Alzheimer's disease	0.00034	0.0029	CcSEcCtD
Bosutinib—Discomfort—Donepezil—Alzheimer's disease	0.00034	0.00289	CcSEcCtD
Bosutinib—Anaemia—Memantine—Alzheimer's disease	0.000339	0.00289	CcSEcCtD
Bosutinib—Abdominal pain—Galantamine—Alzheimer's disease	0.000336	0.00286	CcSEcCtD
Bosutinib—Body temperature increased—Galantamine—Alzheimer's disease	0.000336	0.00286	CcSEcCtD
Bosutinib—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000333	0.00283	CcSEcCtD
Bosutinib—Anaemia—Rivastigmine—Alzheimer's disease	0.000331	0.00282	CcSEcCtD
Bosutinib—Malaise—Memantine—Alzheimer's disease	0.000331	0.00282	CcSEcCtD
Bosutinib—Oedema—Donepezil—Alzheimer's disease	0.000329	0.00281	CcSEcCtD
Bosutinib—Leukopenia—Memantine—Alzheimer's disease	0.000328	0.00279	CcSEcCtD
Bosutinib—Infection—Donepezil—Alzheimer's disease	0.000327	0.00279	CcSEcCtD
Bosutinib—Malaise—Rivastigmine—Alzheimer's disease	0.000323	0.00275	CcSEcCtD
Bosutinib—Gefitinib—CYP2D6—Alzheimer's disease	0.000323	0.254	CrCbGaD
Bosutinib—Nervous system disorder—Donepezil—Alzheimer's disease	0.000323	0.00275	CcSEcCtD
Bosutinib—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000323	0.00275	CcSEcCtD
Bosutinib—Cough—Memantine—Alzheimer's disease	0.00032	0.00272	CcSEcCtD
Bosutinib—Cough—Rivastigmine—Alzheimer's disease	0.000313	0.00267	CcSEcCtD
Bosutinib—Arthralgia—Memantine—Alzheimer's disease	0.000312	0.00266	CcSEcCtD
Bosutinib—Chest pain—Memantine—Alzheimer's disease	0.000312	0.00266	CcSEcCtD
Bosutinib—Myalgia—Memantine—Alzheimer's disease	0.000312	0.00266	CcSEcCtD
Bosutinib—Discomfort—Memantine—Alzheimer's disease	0.000308	0.00263	CcSEcCtD
Bosutinib—Chest pain—Rivastigmine—Alzheimer's disease	0.000305	0.0026	CcSEcCtD
Bosutinib—Arthralgia—Rivastigmine—Alzheimer's disease	0.000305	0.0026	CcSEcCtD
Bosutinib—Myalgia—Rivastigmine—Alzheimer's disease	0.000305	0.0026	CcSEcCtD
Bosutinib—Asthenia—Galantamine—Alzheimer's disease	0.000305	0.0026	CcSEcCtD
Bosutinib—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000303	0.00258	CcSEcCtD
Bosutinib—Discomfort—Rivastigmine—Alzheimer's disease	0.000302	0.00257	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.0003	0.00256	CcSEcCtD
Bosutinib—Oedema—Memantine—Alzheimer's disease	0.000299	0.00255	CcSEcCtD
Bosutinib—Infection—Memantine—Alzheimer's disease	0.000297	0.00253	CcSEcCtD
Bosutinib—Dyspnoea—Donepezil—Alzheimer's disease	0.000294	0.0025	CcSEcCtD
Bosutinib—Nervous system disorder—Memantine—Alzheimer's disease	0.000293	0.0025	CcSEcCtD
Bosutinib—Thrombocytopenia—Memantine—Alzheimer's disease	0.000293	0.00249	CcSEcCtD
Bosutinib—Oedema—Rivastigmine—Alzheimer's disease	0.000293	0.00249	CcSEcCtD
Bosutinib—Diarrhoea—Galantamine—Alzheimer's disease	0.000291	0.00248	CcSEcCtD
Bosutinib—Infection—Rivastigmine—Alzheimer's disease	0.000291	0.00248	CcSEcCtD
Bosutinib—Skin disorder—Memantine—Alzheimer's disease	0.000291	0.00248	CcSEcCtD
Bosutinib—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000287	0.00244	CcSEcCtD
Bosutinib—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000286	0.00244	CcSEcCtD
Bosutinib—Decreased appetite—Donepezil—Alzheimer's disease	0.000286	0.00244	CcSEcCtD
Bosutinib—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000284	0.00242	CcSEcCtD
Bosutinib—Skin disorder—Rivastigmine—Alzheimer's disease	0.000284	0.00242	CcSEcCtD
Bosutinib—Fatigue—Donepezil—Alzheimer's disease	0.000284	0.00242	CcSEcCtD
Bosutinib—Pain—Donepezil—Alzheimer's disease	0.000282	0.0024	CcSEcCtD
Bosutinib—Dizziness—Galantamine—Alzheimer's disease	0.000281	0.00239	CcSEcCtD
Bosutinib—FES—brain—Alzheimer's disease	0.000274	0.00218	CbGeAlD
Bosutinib—VRK2—brain—Alzheimer's disease	0.000274	0.00218	CbGeAlD
Bosutinib—CAMK1D—cerebellum—Alzheimer's disease	0.000273	0.00217	CbGeAlD
Bosutinib—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000273	0.00232	CcSEcCtD
Bosutinib—MAP3K19—nervous system—Alzheimer's disease	0.000272	0.00216	CbGeAlD
Bosutinib—Feeling abnormal—Donepezil—Alzheimer's disease	0.000271	0.00231	CcSEcCtD
Bosutinib—Vomiting—Galantamine—Alzheimer's disease	0.00027	0.0023	CcSEcCtD
Bosutinib—STK24—cerebellum—Alzheimer's disease	0.00027	0.00215	CbGeAlD
Bosutinib—YES1—telencephalon—Alzheimer's disease	0.00027	0.00215	CbGeAlD
Bosutinib—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000269	0.00229	CcSEcCtD
Bosutinib—SYK—brain—Alzheimer's disease	0.000269	0.00214	CbGeAlD
Bosutinib—TNIK—brain—Alzheimer's disease	0.000269	0.00214	CbGeAlD
Bosutinib—Rash—Galantamine—Alzheimer's disease	0.000268	0.00228	CcSEcCtD
Bosutinib—Dermatitis—Galantamine—Alzheimer's disease	0.000268	0.00228	CcSEcCtD
Bosutinib—ALK—central nervous system—Alzheimer's disease	0.000267	0.00213	CbGeAlD
Bosutinib—FER—central nervous system—Alzheimer's disease	0.000267	0.00213	CbGeAlD
Bosutinib—TYRO3—central nervous system—Alzheimer's disease	0.000267	0.00213	CbGeAlD
Bosutinib—EPHA5—central nervous system—Alzheimer's disease	0.000267	0.00213	CbGeAlD
Bosutinib—TNK2—nervous system—Alzheimer's disease	0.000267	0.00212	CbGeAlD
Bosutinib—Dyspnoea—Memantine—Alzheimer's disease	0.000267	0.00227	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000267	0.00227	CcSEcCtD
Bosutinib—CDK2—brain—Alzheimer's disease	0.000267	0.00212	CbGeAlD
Bosutinib—TAOK3—telencephalon—Alzheimer's disease	0.000266	0.00212	CbGeAlD
Bosutinib—Headache—Galantamine—Alzheimer's disease	0.000266	0.00227	CcSEcCtD
Bosutinib—LYN—central nervous system—Alzheimer's disease	0.000266	0.00212	CbGeAlD
Bosutinib—STK26—brain—Alzheimer's disease	0.000264	0.0021	CbGeAlD
Bosutinib—MAP3K19—central nervous system—Alzheimer's disease	0.000262	0.00208	CbGeAlD
Bosutinib—Urticaria—Donepezil—Alzheimer's disease	0.000262	0.00223	CcSEcCtD
Bosutinib—FER—cerebellum—Alzheimer's disease	0.000261	0.00208	CbGeAlD
Bosutinib—EPHA5—cerebellum—Alzheimer's disease	0.000261	0.00208	CbGeAlD
Bosutinib—TYRO3—cerebellum—Alzheimer's disease	0.000261	0.00208	CbGeAlD
Bosutinib—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000261	0.00222	CcSEcCtD
Bosutinib—Abdominal pain—Donepezil—Alzheimer's disease	0.00026	0.00222	CcSEcCtD
Bosutinib—Body temperature increased—Donepezil—Alzheimer's disease	0.00026	0.00222	CcSEcCtD
Bosutinib—Decreased appetite—Memantine—Alzheimer's disease	0.00026	0.00222	CcSEcCtD
Bosutinib—SRC—telencephalon—Alzheimer's disease	0.00026	0.00206	CbGeAlD
Bosutinib—ERBB4—nervous system—Alzheimer's disease	0.00026	0.00206	CbGeAlD
Bosutinib—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000258	0.0022	CcSEcCtD
Bosutinib—Fatigue—Memantine—Alzheimer's disease	0.000258	0.0022	CcSEcCtD
Bosutinib—TNK2—central nervous system—Alzheimer's disease	0.000257	0.00204	CbGeAlD
Bosutinib—ROCK1—nervous system—Alzheimer's disease	0.000256	0.00204	CbGeAlD
Bosutinib—Pain—Memantine—Alzheimer's disease	0.000256	0.00218	CcSEcCtD
Bosutinib—CHEK2—brain—Alzheimer's disease	0.000255	0.00203	CbGeAlD
Bosutinib—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000254	0.00217	CcSEcCtD
Bosutinib—PDGFRB—embryo—Alzheimer's disease	0.000254	0.00202	CbGeAlD
Bosutinib—CSF1R—forebrain—Alzheimer's disease	0.000253	0.00202	CbGeAlD
Bosutinib—WEE1—brain—Alzheimer's disease	0.000253	0.00201	CbGeAlD
Bosutinib—DMPK—brain—Alzheimer's disease	0.000253	0.00201	CbGeAlD
Bosutinib—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000253	0.00215	CcSEcCtD
Bosutinib—Nausea—Galantamine—Alzheimer's disease	0.000252	0.00215	CcSEcCtD
Bosutinib—Fatigue—Rivastigmine—Alzheimer's disease	0.000252	0.00215	CcSEcCtD
Bosutinib—TNK2—cerebellum—Alzheimer's disease	0.000251	0.002	CbGeAlD
Bosutinib—Pain—Rivastigmine—Alzheimer's disease	0.00025	0.00213	CcSEcCtD
Bosutinib—ERBB4—central nervous system—Alzheimer's disease	0.00025	0.00199	CbGeAlD
Bosutinib—BMPR2—nervous system—Alzheimer's disease	0.000249	0.00198	CbGeAlD
Bosutinib—MAP4K2—cerebellum—Alzheimer's disease	0.000248	0.00197	CbGeAlD
Bosutinib—STK36—nervous system—Alzheimer's disease	0.000247	0.00196	CbGeAlD
Bosutinib—EPHB3—nervous system—Alzheimer's disease	0.000247	0.00196	CbGeAlD
Bosutinib—ROCK1—central nervous system—Alzheimer's disease	0.000247	0.00196	CbGeAlD
Bosutinib—Feeling abnormal—Memantine—Alzheimer's disease	0.000246	0.0021	CcSEcCtD
Bosutinib—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000245	0.00208	CcSEcCtD
Bosutinib—STK3—cerebellum—Alzheimer's disease	0.000244	0.00194	CbGeAlD
Bosutinib—ERBB4—cerebellum—Alzheimer's disease	0.000244	0.00194	CbGeAlD
Bosutinib—MERTK—nervous system—Alzheimer's disease	0.000244	0.00194	CbGeAlD
Bosutinib—STK25—brain—Alzheimer's disease	0.000242	0.00192	CbGeAlD
Bosutinib—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000241	0.00205	CcSEcCtD
Bosutinib—EPHA3—brain—Alzheimer's disease	0.00024	0.00191	CbGeAlD
Bosutinib—BMPR2—central nervous system—Alzheimer's disease	0.00024	0.00191	CbGeAlD
Bosutinib—MAP4K4—nervous system—Alzheimer's disease	0.00024	0.0019	CbGeAlD
Bosutinib—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000239	0.00204	CcSEcCtD
Bosutinib—MAP2K5—telencephalon—Alzheimer's disease	0.000239	0.0019	CbGeAlD
Bosutinib—BCR—nervous system—Alzheimer's disease	0.000238	0.00189	CbGeAlD
Bosutinib—EPHB3—central nervous system—Alzheimer's disease	0.000238	0.00189	CbGeAlD
Bosutinib—STK36—central nervous system—Alzheimer's disease	0.000238	0.00189	CbGeAlD
Bosutinib—Urticaria—Memantine—Alzheimer's disease	0.000238	0.00202	CcSEcCtD
Bosutinib—Abdominal pain—Memantine—Alzheimer's disease	0.000236	0.00201	CcSEcCtD
Bosutinib—Body temperature increased—Memantine—Alzheimer's disease	0.000236	0.00201	CcSEcCtD
Bosutinib—Asthenia—Donepezil—Alzheimer's disease	0.000236	0.00201	CcSEcCtD
Bosutinib—MAP3K12—nervous system—Alzheimer's disease	0.000236	0.00188	CbGeAlD
Bosutinib—MERTK—central nervous system—Alzheimer's disease	0.000235	0.00187	CbGeAlD
Bosutinib—PLK2—brain—Alzheimer's disease	0.000235	0.00187	CbGeAlD
Bosutinib—BMPR2—cerebellum—Alzheimer's disease	0.000234	0.00186	CbGeAlD
Bosutinib—SIK3—brain—Alzheimer's disease	0.000233	0.00186	CbGeAlD
Bosutinib—Pruritus—Donepezil—Alzheimer's disease	0.000233	0.00199	CcSEcCtD
Bosutinib—CSF1R—telencephalon—Alzheimer's disease	0.000233	0.00185	CbGeAlD
Bosutinib—Urticaria—Rivastigmine—Alzheimer's disease	0.000232	0.00198	CcSEcCtD
Bosutinib—STK36—cerebellum—Alzheimer's disease	0.000232	0.00185	CbGeAlD
Bosutinib—EPHB3—cerebellum—Alzheimer's disease	0.000232	0.00185	CbGeAlD
Bosutinib—MAP2K1—nervous system—Alzheimer's disease	0.000231	0.00184	CbGeAlD
Bosutinib—STK35—nervous system—Alzheimer's disease	0.000231	0.00184	CbGeAlD
Bosutinib—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000231	0.00197	CcSEcCtD
Bosutinib—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000231	0.00197	CcSEcCtD
Bosutinib—MAP4K4—central nervous system—Alzheimer's disease	0.000231	0.00183	CbGeAlD
Bosutinib—CSK—nervous system—Alzheimer's disease	0.00023	0.00183	CbGeAlD
Bosutinib—MERTK—cerebellum—Alzheimer's disease	0.00023	0.00183	CbGeAlD
Bosutinib—BCR—central nervous system—Alzheimer's disease	0.000229	0.00182	CbGeAlD
Bosutinib—CSNK1A1—nervous system—Alzheimer's disease	0.000228	0.00182	CbGeAlD
Bosutinib—MAP3K12—central nervous system—Alzheimer's disease	0.000227	0.00181	CbGeAlD
Bosutinib—HCK—nervous system—Alzheimer's disease	0.000227	0.0018	CbGeAlD
Bosutinib—CLK1—nervous system—Alzheimer's disease	0.000227	0.0018	CbGeAlD
Bosutinib—ABL1—embryo—Alzheimer's disease	0.000226	0.0018	CbGeAlD
Bosutinib—MAP4K4—cerebellum—Alzheimer's disease	0.000225	0.00179	CbGeAlD
Bosutinib—Diarrhoea—Donepezil—Alzheimer's disease	0.000225	0.00192	CcSEcCtD
Bosutinib—STK4—brain—Alzheimer's disease	0.000225	0.00179	CbGeAlD
Bosutinib—BCR—cerebellum—Alzheimer's disease	0.000224	0.00178	CbGeAlD
Bosutinib—NUAK2—cerebellum—Alzheimer's disease	0.000224	0.00178	CbGeAlD
Bosutinib—MAP2K1—central nervous system—Alzheimer's disease	0.000223	0.00177	CbGeAlD
Bosutinib—STK35—central nervous system—Alzheimer's disease	0.000223	0.00177	CbGeAlD
Bosutinib—CAMK2G—nervous system—Alzheimer's disease	0.000223	0.00177	CbGeAlD
Bosutinib—BMP2K—nervous system—Alzheimer's disease	0.000223	0.00177	CbGeAlD
Bosutinib—MAP3K12—cerebellum—Alzheimer's disease	0.000222	0.00177	CbGeAlD
Bosutinib—CAMK1D—brain—Alzheimer's disease	0.000222	0.00176	CbGeAlD
Bosutinib—CSK—central nervous system—Alzheimer's disease	0.000221	0.00176	CbGeAlD
Bosutinib—LRRK2—nervous system—Alzheimer's disease	0.000221	0.00176	CbGeAlD
Bosutinib—CSNK1A1—central nervous system—Alzheimer's disease	0.00022	0.00175	CbGeAlD
Bosutinib—STK24—brain—Alzheimer's disease	0.000219	0.00174	CbGeAlD
Bosutinib—HCK—central nervous system—Alzheimer's disease	0.000218	0.00174	CbGeAlD
Bosutinib—CLK1—central nervous system—Alzheimer's disease	0.000218	0.00174	CbGeAlD
Bosutinib—Dizziness—Donepezil—Alzheimer's disease	0.000218	0.00186	CcSEcCtD
Bosutinib—MAP2K1—cerebellum—Alzheimer's disease	0.000218	0.00173	CbGeAlD
Bosutinib—STK35—cerebellum—Alzheimer's disease	0.000218	0.00173	CbGeAlD
Bosutinib—CSK—cerebellum—Alzheimer's disease	0.000216	0.00172	CbGeAlD
Bosutinib—PTK2B—nervous system—Alzheimer's disease	0.000215	0.00171	CbGeAlD
Bosutinib—CSNK1A1—cerebellum—Alzheimer's disease	0.000215	0.00171	CbGeAlD
Bosutinib—Asthenia—Memantine—Alzheimer's disease	0.000215	0.00183	CcSEcCtD
Bosutinib—BMP2K—central nervous system—Alzheimer's disease	0.000214	0.0017	CbGeAlD
Bosutinib—CAMK2G—central nervous system—Alzheimer's disease	0.000214	0.0017	CbGeAlD
Bosutinib—CLK1—cerebellum—Alzheimer's disease	0.000213	0.0017	CbGeAlD
Bosutinib—LRRK2—central nervous system—Alzheimer's disease	0.000212	0.00169	CbGeAlD
Bosutinib—FER—brain—Alzheimer's disease	0.000212	0.00169	CbGeAlD
Bosutinib—EPHA5—brain—Alzheimer's disease	0.000212	0.00169	CbGeAlD
Bosutinib—TYRO3—brain—Alzheimer's disease	0.000212	0.00169	CbGeAlD
Bosutinib—ALK—brain—Alzheimer's disease	0.000212	0.00169	CbGeAlD
Bosutinib—ABL2—cerebellum—Alzheimer's disease	0.000212	0.00169	CbGeAlD
Bosutinib—Pruritus—Memantine—Alzheimer's disease	0.000212	0.0018	CcSEcCtD
Bosutinib—CSNK1E—nervous system—Alzheimer's disease	0.000212	0.00168	CbGeAlD
Bosutinib—LYN—brain—Alzheimer's disease	0.000211	0.00168	CbGeAlD
Bosutinib—Asthenia—Rivastigmine—Alzheimer's disease	0.00021	0.00179	CcSEcCtD
Bosutinib—BMP2K—cerebellum—Alzheimer's disease	0.00021	0.00167	CbGeAlD
Bosutinib—CAMK2G—cerebellum—Alzheimer's disease	0.00021	0.00167	CbGeAlD
Bosutinib—Vomiting—Donepezil—Alzheimer's disease	0.000209	0.00178	CcSEcCtD
Bosutinib—SIK1—nervous system—Alzheimer's disease	0.000208	0.00166	CbGeAlD
Bosutinib—IRAK4—nervous system—Alzheimer's disease	0.000208	0.00166	CbGeAlD
Bosutinib—MAP3K19—brain—Alzheimer's disease	0.000208	0.00165	CbGeAlD
Bosutinib—MAP4K1—brain—Alzheimer's disease	0.000208	0.00165	CbGeAlD
Bosutinib—Rash—Donepezil—Alzheimer's disease	0.000208	0.00177	CcSEcCtD
Bosutinib—LRRK2—cerebellum—Alzheimer's disease	0.000208	0.00165	CbGeAlD
Bosutinib—Dermatitis—Donepezil—Alzheimer's disease	0.000208	0.00177	CcSEcCtD
Bosutinib—EGFR—cerebellum—Alzheimer's disease	0.000207	0.00165	CbGeAlD
Bosutinib—PTK2B—central nervous system—Alzheimer's disease	0.000207	0.00165	CbGeAlD
Bosutinib—Pruritus—Rivastigmine—Alzheimer's disease	0.000207	0.00176	CcSEcCtD
Bosutinib—BTK—brain—Alzheimer's disease	0.000207	0.00165	CbGeAlD
Bosutinib—PDGFRB—telencephalon—Alzheimer's disease	0.000207	0.00164	CbGeAlD
Bosutinib—Headache—Donepezil—Alzheimer's disease	0.000206	0.00176	CcSEcCtD
Bosutinib—EPHA4—nervous system—Alzheimer's disease	0.000206	0.00164	CbGeAlD
Bosutinib—Diarrhoea—Memantine—Alzheimer's disease	0.000205	0.00174	CcSEcCtD
Bosutinib—ERBB3—nervous system—Alzheimer's disease	0.000204	0.00162	CbGeAlD
Bosutinib—TNK2—brain—Alzheimer's disease	0.000204	0.00162	CbGeAlD
Bosutinib—CSNK1E—central nervous system—Alzheimer's disease	0.000204	0.00162	CbGeAlD
Bosutinib—ULK3—nervous system—Alzheimer's disease	0.000204	0.00162	CbGeAlD
Bosutinib—MAP2K2—nervous system—Alzheimer's disease	0.000204	0.00162	CbGeAlD
Bosutinib—PTK2B—cerebellum—Alzheimer's disease	0.000202	0.00161	CbGeAlD
Bosutinib—MAP3K2—nervous system—Alzheimer's disease	0.000202	0.00161	CbGeAlD
Bosutinib—MAP4K2—brain—Alzheimer's disease	0.000201	0.0016	CbGeAlD
Bosutinib—SIK1—central nervous system—Alzheimer's disease	0.000201	0.00159	CbGeAlD
Bosutinib—IRAK4—central nervous system—Alzheimer's disease	0.000201	0.00159	CbGeAlD
Bosutinib—Diarrhoea—Rivastigmine—Alzheimer's disease	0.0002	0.00171	CcSEcCtD
Bosutinib—CSNK1E—cerebellum—Alzheimer's disease	0.000199	0.00158	CbGeAlD
Bosutinib—EPHA4—central nervous system—Alzheimer's disease	0.000199	0.00158	CbGeAlD
Bosutinib—ERBB4—brain—Alzheimer's disease	0.000198	0.00158	CbGeAlD
Bosutinib—STK3—brain—Alzheimer's disease	0.000198	0.00158	CbGeAlD
Bosutinib—PTK2—nervous system—Alzheimer's disease	0.000198	0.00157	CbGeAlD
Bosutinib—TBK1—nervous system—Alzheimer's disease	0.000198	0.00157	CbGeAlD
Bosutinib—Dizziness—Memantine—Alzheimer's disease	0.000198	0.00169	CcSEcCtD
Bosutinib—ERBB3—central nervous system—Alzheimer's disease	0.000197	0.00156	CbGeAlD
Bosutinib—MAP2K2—central nervous system—Alzheimer's disease	0.000196	0.00156	CbGeAlD
Bosutinib—ULK3—central nervous system—Alzheimer's disease	0.000196	0.00156	CbGeAlD
Bosutinib—SIK1—cerebellum—Alzheimer's disease	0.000196	0.00156	CbGeAlD
Bosutinib—IRAK4—cerebellum—Alzheimer's disease	0.000196	0.00156	CbGeAlD
Bosutinib—ROCK1—brain—Alzheimer's disease	0.000196	0.00156	CbGeAlD
Bosutinib—Nausea—Donepezil—Alzheimer's disease	0.000196	0.00167	CcSEcCtD
Bosutinib—MAP3K2—central nervous system—Alzheimer's disease	0.000195	0.00155	CbGeAlD
Bosutinib—EPHA4—cerebellum—Alzheimer's disease	0.000194	0.00154	CbGeAlD
Bosutinib—Dizziness—Rivastigmine—Alzheimer's disease	0.000193	0.00165	CcSEcCtD
Bosutinib—ERBB3—cerebellum—Alzheimer's disease	0.000192	0.00153	CbGeAlD
Bosutinib—MAP2K2—cerebellum—Alzheimer's disease	0.000192	0.00152	CbGeAlD
Bosutinib—ULK3—cerebellum—Alzheimer's disease	0.000192	0.00152	CbGeAlD
Bosutinib—TBK1—central nervous system—Alzheimer's disease	0.000191	0.00152	CbGeAlD
Bosutinib—PTK2—central nervous system—Alzheimer's disease	0.000191	0.00152	CbGeAlD
Bosutinib—RPS6KB1—nervous system—Alzheimer's disease	0.000191	0.00151	CbGeAlD
Bosutinib—MAP3K2—cerebellum—Alzheimer's disease	0.00019	0.00151	CbGeAlD
Bosutinib—BMPR2—brain—Alzheimer's disease	0.00019	0.00151	CbGeAlD
Bosutinib—Vomiting—Memantine—Alzheimer's disease	0.00019	0.00162	CcSEcCtD
Bosutinib—FGR—nervous system—Alzheimer's disease	0.000189	0.00151	CbGeAlD
Bosutinib—EPHB3—brain—Alzheimer's disease	0.000189	0.0015	CbGeAlD
Bosutinib—STK36—brain—Alzheimer's disease	0.000189	0.0015	CbGeAlD
Bosutinib—Rash—Memantine—Alzheimer's disease	0.000189	0.00161	CcSEcCtD
Bosutinib—AXL—nervous system—Alzheimer's disease	0.000189	0.0015	CbGeAlD
Bosutinib—MAP3K7—cerebellum—Alzheimer's disease	0.000188	0.0015	CbGeAlD
Bosutinib—Dermatitis—Memantine—Alzheimer's disease	0.000188	0.00161	CcSEcCtD
Bosutinib—Headache—Memantine—Alzheimer's disease	0.000187	0.0016	CcSEcCtD
Bosutinib—MERTK—brain—Alzheimer's disease	0.000187	0.00148	CbGeAlD
Bosutinib—TBK1—cerebellum—Alzheimer's disease	0.000186	0.00148	CbGeAlD
Bosutinib—PTK2—cerebellum—Alzheimer's disease	0.000186	0.00148	CbGeAlD
Bosutinib—Vomiting—Rivastigmine—Alzheimer's disease	0.000186	0.00158	CcSEcCtD
Bosutinib—Rash—Rivastigmine—Alzheimer's disease	0.000184	0.00157	CcSEcCtD
Bosutinib—Dermatitis—Rivastigmine—Alzheimer's disease	0.000184	0.00157	CcSEcCtD
Bosutinib—ABL1—telencephalon—Alzheimer's disease	0.000184	0.00146	CbGeAlD
Bosutinib—RPS6KB1—central nervous system—Alzheimer's disease	0.000183	0.00146	CbGeAlD
Bosutinib—Headache—Rivastigmine—Alzheimer's disease	0.000183	0.00156	CcSEcCtD
Bosutinib—MAP4K4—brain—Alzheimer's disease	0.000183	0.00146	CbGeAlD
Bosutinib—IRAK1—cerebellum—Alzheimer's disease	0.000183	0.00145	CbGeAlD
Bosutinib—FGR—central nervous system—Alzheimer's disease	0.000182	0.00145	CbGeAlD
Bosutinib—BCR—brain—Alzheimer's disease	0.000182	0.00145	CbGeAlD
Bosutinib—NUAK2—brain—Alzheimer's disease	0.000182	0.00145	CbGeAlD
Bosutinib—AXL—central nervous system—Alzheimer's disease	0.000182	0.00144	CbGeAlD
Bosutinib—MAP3K12—brain—Alzheimer's disease	0.00018	0.00144	CbGeAlD
Bosutinib—RPS6KB1—cerebellum—Alzheimer's disease	0.000179	0.00143	CbGeAlD
Bosutinib—Nausea—Memantine—Alzheimer's disease	0.000178	0.00151	CcSEcCtD
Bosutinib—AXL—cerebellum—Alzheimer's disease	0.000177	0.00141	CbGeAlD
Bosutinib—MAP2K1—brain—Alzheimer's disease	0.000177	0.00141	CbGeAlD
Bosutinib—STK35—brain—Alzheimer's disease	0.000177	0.00141	CbGeAlD
Bosutinib—EPHA2—nervous system—Alzheimer's disease	0.000177	0.00141	CbGeAlD
Bosutinib—FYN—nervous system—Alzheimer's disease	0.000177	0.0014	CbGeAlD
Bosutinib—CSK—brain—Alzheimer's disease	0.000176	0.0014	CbGeAlD
Bosutinib—CSNK1A1—brain—Alzheimer's disease	0.000175	0.00139	CbGeAlD
Bosutinib—Nausea—Rivastigmine—Alzheimer's disease	0.000174	0.00148	CcSEcCtD
Bosutinib—HCK—brain—Alzheimer's disease	0.000173	0.00138	CbGeAlD
Bosutinib—CLK1—brain—Alzheimer's disease	0.000173	0.00138	CbGeAlD
Bosutinib—MAP3K3—nervous system—Alzheimer's disease	0.000172	0.00137	CbGeAlD
Bosutinib—MAP4K5—nervous system—Alzheimer's disease	0.000172	0.00137	CbGeAlD
Bosutinib—ABL2—brain—Alzheimer's disease	0.000172	0.00137	CbGeAlD
Bosutinib—SLK—cerebellum—Alzheimer's disease	0.000171	0.00136	CbGeAlD
Bosutinib—EPHA2—central nervous system—Alzheimer's disease	0.00017	0.00135	CbGeAlD
Bosutinib—CAMK2G—brain—Alzheimer's disease	0.00017	0.00135	CbGeAlD
Bosutinib—BMP2K—brain—Alzheimer's disease	0.00017	0.00135	CbGeAlD
Bosutinib—FYN—central nervous system—Alzheimer's disease	0.00017	0.00135	CbGeAlD
Bosutinib—EPHB4—cerebellum—Alzheimer's disease	0.00017	0.00135	CbGeAlD
Bosutinib—LRRK2—brain—Alzheimer's disease	0.000169	0.00134	CbGeAlD
Bosutinib—EGFR—brain—Alzheimer's disease	0.000168	0.00134	CbGeAlD
Bosutinib—FYN—cerebellum—Alzheimer's disease	0.000166	0.00132	CbGeAlD
Bosutinib—MAP3K3—central nervous system—Alzheimer's disease	0.000166	0.00132	CbGeAlD
Bosutinib—MAP4K5—central nervous system—Alzheimer's disease	0.000166	0.00132	CbGeAlD
Bosutinib—PTK2B—brain—Alzheimer's disease	0.000164	0.00131	CbGeAlD
Bosutinib—MAP3K3—cerebellum—Alzheimer's disease	0.000162	0.00129	CbGeAlD
Bosutinib—MAP4K5—cerebellum—Alzheimer's disease	0.000162	0.00129	CbGeAlD
Bosutinib—CSNK1E—brain—Alzheimer's disease	0.000162	0.00129	CbGeAlD
Bosutinib—YES1—nervous system—Alzheimer's disease	0.000159	0.00127	CbGeAlD
Bosutinib—SIK1—brain—Alzheimer's disease	0.000159	0.00127	CbGeAlD
Bosutinib—IRAK4—brain—Alzheimer's disease	0.000159	0.00127	CbGeAlD
Bosutinib—STK10—nervous system—Alzheimer's disease	0.000158	0.00126	CbGeAlD
Bosutinib—EPHA4—brain—Alzheimer's disease	0.000158	0.00125	CbGeAlD
Bosutinib—TAOK3—nervous system—Alzheimer's disease	0.000157	0.00125	CbGeAlD
Bosutinib—ERBB3—brain—Alzheimer's disease	0.000156	0.00124	CbGeAlD
Bosutinib—MAP2K2—brain—Alzheimer's disease	0.000156	0.00124	CbGeAlD
Bosutinib—ULK3—brain—Alzheimer's disease	0.000156	0.00124	CbGeAlD
Bosutinib—MAP3K2—brain—Alzheimer's disease	0.000155	0.00123	CbGeAlD
Bosutinib—YES1—central nervous system—Alzheimer's disease	0.000153	0.00122	CbGeAlD
Bosutinib—SRC—nervous system—Alzheimer's disease	0.000153	0.00122	CbGeAlD
Bosutinib—MAP3K7—brain—Alzheimer's disease	0.000153	0.00122	CbGeAlD
Bosutinib—STK10—central nervous system—Alzheimer's disease	0.000152	0.00121	CbGeAlD
Bosutinib—TAOK3—central nervous system—Alzheimer's disease	0.000151	0.0012	CbGeAlD
Bosutinib—TBK1—brain—Alzheimer's disease	0.000151	0.0012	CbGeAlD
Bosutinib—PTK2—brain—Alzheimer's disease	0.000151	0.0012	CbGeAlD
Bosutinib—YES1—cerebellum—Alzheimer's disease	0.00015	0.00119	CbGeAlD
Bosutinib—STK10—cerebellum—Alzheimer's disease	0.000149	0.00118	CbGeAlD
Bosutinib—IRAK1—brain—Alzheimer's disease	0.000148	0.00118	CbGeAlD
Bosutinib—TAOK3—cerebellum—Alzheimer's disease	0.000148	0.00118	CbGeAlD
Bosutinib—SRC—central nervous system—Alzheimer's disease	0.000148	0.00117	CbGeAlD
Bosutinib—RPS6KB1—brain—Alzheimer's disease	0.000146	0.00116	CbGeAlD
Bosutinib—FGR—brain—Alzheimer's disease	0.000145	0.00115	CbGeAlD
Bosutinib—SRC—cerebellum—Alzheimer's disease	0.000144	0.00115	CbGeAlD
Bosutinib—AXL—brain—Alzheimer's disease	0.000144	0.00115	CbGeAlD
Bosutinib—MAP2K5—nervous system—Alzheimer's disease	0.000141	0.00112	CbGeAlD
Bosutinib—SLK—brain—Alzheimer's disease	0.000139	0.0011	CbGeAlD
Bosutinib—EPHB4—brain—Alzheimer's disease	0.000138	0.0011	CbGeAlD
Bosutinib—CSF1R—nervous system—Alzheimer's disease	0.000138	0.00109	CbGeAlD
Bosutinib—MAP2K5—central nervous system—Alzheimer's disease	0.000136	0.00108	CbGeAlD
Bosutinib—EPHA2—brain—Alzheimer's disease	0.000135	0.00107	CbGeAlD
Bosutinib—FYN—brain—Alzheimer's disease	0.000135	0.00107	CbGeAlD
Bosutinib—MAP2K5—cerebellum—Alzheimer's disease	0.000133	0.00105	CbGeAlD
Bosutinib—CSF1R—central nervous system—Alzheimer's disease	0.000132	0.00105	CbGeAlD
Bosutinib—MAP3K3—brain—Alzheimer's disease	0.000132	0.00105	CbGeAlD
Bosutinib—MAP4K5—brain—Alzheimer's disease	0.000132	0.00105	CbGeAlD
Bosutinib—CSF1R—cerebellum—Alzheimer's disease	0.000129	0.00103	CbGeAlD
Bosutinib—PDGFRB—nervous system—Alzheimer's disease	0.000122	0.00097	CbGeAlD
Bosutinib—YES1—brain—Alzheimer's disease	0.000122	0.000968	CbGeAlD
Bosutinib—STK10—brain—Alzheimer's disease	0.000121	0.00096	CbGeAlD
Bosutinib—TAOK3—brain—Alzheimer's disease	0.00012	0.000956	CbGeAlD
Bosutinib—ABCB1—blood vessel—Alzheimer's disease	0.000118	0.000939	CbGeAlD
Bosutinib—PDGFRB—central nervous system—Alzheimer's disease	0.000117	0.000934	CbGeAlD
Bosutinib—SRC—brain—Alzheimer's disease	0.000117	0.000931	CbGeAlD
Bosutinib—PDGFRB—cerebellum—Alzheimer's disease	0.000115	0.000913	CbGeAlD
Bosutinib—ABL1—nervous system—Alzheimer's disease	0.000109	0.000865	CbGeAlD
Bosutinib—MAP2K5—brain—Alzheimer's disease	0.000108	0.000857	CbGeAlD
Bosutinib—CSF1R—brain—Alzheimer's disease	0.000105	0.000836	CbGeAlD
Bosutinib—ABL1—central nervous system—Alzheimer's disease	0.000105	0.000833	CbGeAlD
Bosutinib—ABL1—cerebellum—Alzheimer's disease	0.000102	0.000814	CbGeAlD
Bosutinib—PDGFRB—brain—Alzheimer's disease	9.33e-05	0.000742	CbGeAlD
Bosutinib—ABL1—brain—Alzheimer's disease	8.31e-05	0.000661	CbGeAlD
Bosutinib—ABCB1—embryo—Alzheimer's disease	7.04e-05	0.00056	CbGeAlD
Bosutinib—ABCB1—forebrain—Alzheimer's disease	6.23e-05	0.000495	CbGeAlD
Bosutinib—ABCB1—telencephalon—Alzheimer's disease	5.73e-05	0.000456	CbGeAlD
Bosutinib—CYP3A4—nervous system—Alzheimer's disease	4.78e-05	0.00038	CbGeAlD
Bosutinib—CYP3A4—central nervous system—Alzheimer's disease	4.6e-05	0.000366	CbGeAlD
Bosutinib—ABCB1—nervous system—Alzheimer's disease	3.38e-05	0.000269	CbGeAlD
Bosutinib—ABCB1—central nervous system—Alzheimer's disease	3.26e-05	0.000259	CbGeAlD
Bosutinib—ABCB1—cerebellum—Alzheimer's disease	3.18e-05	0.000253	CbGeAlD
Bosutinib—ABCB1—brain—Alzheimer's disease	2.58e-05	0.000206	CbGeAlD
Bosutinib—ABCB1—Metabolism—PLCB1—Alzheimer's disease	7.48e-07	3.43e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—F2—Alzheimer's disease	7.45e-07	3.42e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—PTGS2—Alzheimer's disease	7.45e-07	3.42e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CCR5—Alzheimer's disease	7.41e-07	3.4e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—MAPK8—Alzheimer's disease	7.39e-07	3.39e-06	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—TGFB1—Alzheimer's disease	7.3e-07	3.35e-06	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—TGFB1—Alzheimer's disease	7.3e-07	3.35e-06	CbGpPWpGaD
Bosutinib—PTK2—Immune System—IL6—Alzheimer's disease	7.29e-07	3.35e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—NOTCH1—Alzheimer's disease	7.29e-07	3.35e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—NOS3—Alzheimer's disease	7.29e-07	3.34e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—MAPK8—Alzheimer's disease	7.28e-07	3.34e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—ESR1—Alzheimer's disease	7.27e-07	3.34e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—ABCA1—Alzheimer's disease	7.25e-07	3.33e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—HTR2A—Alzheimer's disease	7.25e-07	3.33e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—TPI1—Alzheimer's disease	7.23e-07	3.32e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CHAT—Alzheimer's disease	7.23e-07	3.32e-06	CbGpPWpGaD
Bosutinib—EGFR—Innate Immune System—AKT1—Alzheimer's disease	7.23e-07	3.32e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—NOS3—Alzheimer's disease	7.21e-07	3.31e-06	CbGpPWpGaD
Bosutinib—YES1—Immune System—IL6—Alzheimer's disease	7.19e-07	3.3e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—F2—Alzheimer's disease	7.18e-07	3.3e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—MAPK8—Alzheimer's disease	7.14e-07	3.28e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—NOS3—Alzheimer's disease	7.11e-07	3.26e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—CASP3—Alzheimer's disease	7.08e-07	3.25e-06	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—TGFB1—Alzheimer's disease	7.03e-07	3.23e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—NOTCH1—Alzheimer's disease	7.03e-07	3.23e-06	CbGpPWpGaD
Bosutinib—SRC—Developmental Biology—AKT1—Alzheimer's disease	6.98e-07	3.2e-06	CbGpPWpGaD
Bosutinib—ERBB3—Disease—AKT1—Alzheimer's disease	6.98e-07	3.2e-06	CbGpPWpGaD
Bosutinib—LCK—Innate Immune System—AKT1—Alzheimer's disease	6.96e-07	3.2e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—NOS3—Alzheimer's disease	6.96e-07	3.19e-06	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—IL6—Alzheimer's disease	6.95e-07	3.19e-06	CbGpPWpGaD
Bosutinib—EGFR—Adaptive Immune System—AKT1—Alzheimer's disease	6.94e-07	3.19e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—MAOB—Alzheimer's disease	6.93e-07	3.18e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—MAPK8—Alzheimer's disease	6.91e-07	3.17e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—MAPK8—Alzheimer's disease	6.89e-07	3.16e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—TGFB1—Alzheimer's disease	6.88e-07	3.16e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—NOS3—Alzheimer's disease	6.85e-07	3.15e-06	CbGpPWpGaD
Bosutinib—SRC—Hemostasis—AKT1—Alzheimer's disease	6.85e-07	3.14e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—GSK3B—Alzheimer's disease	6.84e-07	3.14e-06	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—IL6—Alzheimer's disease	6.82e-07	3.13e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—VEGFA—Alzheimer's disease	6.82e-07	3.13e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—NOS3—Alzheimer's disease	6.82e-07	3.13e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—CREB1—Alzheimer's disease	6.79e-07	3.12e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CALM1—Alzheimer's disease	6.77e-07	3.11e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—INS—Alzheimer's disease	6.75e-07	3.1e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—APOE—Alzheimer's disease	6.74e-07	3.09e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—LEP—Alzheimer's disease	6.74e-07	3.09e-06	CbGpPWpGaD
Bosutinib—PTK2—Immune System—AKT1—Alzheimer's disease	6.73e-07	3.09e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—VEGFA—Alzheimer's disease	6.73e-07	3.09e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—TGFB1—Alzheimer's disease	6.71e-07	3.08e-06	CbGpPWpGaD
Bosutinib—LCK—Adaptive Immune System—AKT1—Alzheimer's disease	6.69e-07	3.07e-06	CbGpPWpGaD
Bosutinib—SRC—Innate Immune System—IL6—Alzheimer's disease	6.68e-07	3.07e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CAV1—Alzheimer's disease	6.68e-07	3.07e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	6.67e-07	3.06e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—IL1B—Alzheimer's disease	6.65e-07	3.05e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—CCL2—Alzheimer's disease	6.64e-07	3.05e-06	CbGpPWpGaD
Bosutinib—YES1—Immune System—AKT1—Alzheimer's disease	6.64e-07	3.05e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—PTGS2—Alzheimer's disease	6.6e-07	3.03e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—GSK3B—Alzheimer's disease	6.6e-07	3.03e-06	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—TP53—Alzheimer's disease	6.57e-07	3.01e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—CREB1—Alzheimer's disease	6.54e-07	3e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—IGF1—Alzheimer's disease	6.53e-07	3e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—INS—Alzheimer's disease	6.51e-07	2.99e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—MAPK8—Alzheimer's disease	6.5e-07	2.99e-06	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—TP53—Alzheimer's disease	6.47e-07	2.97e-06	CbGpPWpGaD
Bosutinib—FYN—Disease—TGFB1—Alzheimer's disease	6.47e-07	2.97e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—A2M—Alzheimer's disease	6.45e-07	2.96e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—ESR1—Alzheimer's disease	6.44e-07	2.95e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—TGFB1—Alzheimer's disease	6.44e-07	2.95e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—IL6—Alzheimer's disease	6.42e-07	2.95e-06	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—AKT1—Alzheimer's disease	6.42e-07	2.94e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—CCL2—Alzheimer's disease	6.4e-07	2.94e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—VEGFA—Alzheimer's disease	6.38e-07	2.93e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—F2—Alzheimer's disease	6.36e-07	2.92e-06	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—AKT1—Alzheimer's disease	6.29e-07	2.89e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—IGF1—Alzheimer's disease	6.29e-07	2.89e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—TGFB1—Alzheimer's disease	6.26e-07	2.87e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	6.25e-07	2.87e-06	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—TP53—Alzheimer's disease	6.23e-07	2.86e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—HMOX1—Alzheimer's disease	6.22e-07	2.86e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—NOTCH1—Alzheimer's disease	6.22e-07	2.86e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—CASP3—Alzheimer's disease	6.19e-07	2.84e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—TGFB1—Alzheimer's disease	6.17e-07	2.83e-06	CbGpPWpGaD
Bosutinib—SRC—Innate Immune System—AKT1—Alzheimer's disease	6.17e-07	2.83e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling by GPCR—IL6—Alzheimer's disease	6.14e-07	2.82e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—MAPK8—Alzheimer's disease	6.1e-07	2.8e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—CASP3—Alzheimer's disease	6.04e-07	2.77e-06	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—IL6—Alzheimer's disease	6.01e-07	2.76e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—VEGFA—Alzheimer's disease	6.01e-07	2.76e-06	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—TP53—Alzheimer's disease	6.01e-07	2.76e-06	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—TP53—Alzheimer's disease	6.01e-07	2.76e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—AKT1—Alzheimer's disease	5.93e-07	2.72e-06	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—IL6—Alzheimer's disease	5.92e-07	2.72e-06	CbGpPWpGaD
Bosutinib—SRC—Adaptive Immune System—AKT1—Alzheimer's disease	5.92e-07	2.72e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—NOS3—Alzheimer's disease	5.92e-07	2.72e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—CASP3—Alzheimer's disease	5.91e-07	2.71e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—TGFB1—Alzheimer's disease	5.85e-07	2.69e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—GSK3B—Alzheimer's disease	5.84e-07	2.68e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—CASP3—Alzheimer's disease	5.82e-07	2.67e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CREB1—Alzheimer's disease	5.79e-07	2.66e-06	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—TP53—Alzheimer's disease	5.79e-07	2.66e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—CASP3—Alzheimer's disease	5.79e-07	2.66e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—INS—Alzheimer's disease	5.76e-07	2.64e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by GPCR—IL6—Alzheimer's disease	5.75e-07	2.64e-06	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—IL6—Alzheimer's disease	5.71e-07	2.62e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—NOS3—Alzheimer's disease	5.71e-07	2.62e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—LPL—Alzheimer's disease	5.69e-07	2.61e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—MAPK8—Alzheimer's disease	5.68e-07	2.61e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling by GPCR—AKT1—Alzheimer's disease	5.67e-07	2.6e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CCL2—Alzheimer's disease	5.67e-07	2.6e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—IL6—Alzheimer's disease	5.61e-07	2.58e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—ACHE—Alzheimer's disease	5.61e-07	2.57e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—TGFB1—Alzheimer's disease	5.59e-07	2.57e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—IGF1—Alzheimer's disease	5.57e-07	2.56e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—MAPK8—Alzheimer's disease	5.55e-07	2.55e-06	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—AKT1—Alzheimer's disease	5.54e-07	2.55e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	5.54e-07	2.54e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—TGFB1—Alzheimer's disease	5.51e-07	2.53e-06	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—IL6—Alzheimer's disease	5.5e-07	2.52e-06	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—IL6—Alzheimer's disease	5.5e-07	2.52e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—IL6—Alzheimer's disease	5.48e-07	2.51e-06	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—AKT1—Alzheimer's disease	5.46e-07	2.51e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—MAPK8—Alzheimer's disease	5.43e-07	2.49e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—TGFB1—Alzheimer's disease	5.39e-07	2.47e-06	CbGpPWpGaD
Bosutinib—LYN—Immune System—IL6—Alzheimer's disease	5.36e-07	2.46e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—MAPK8—Alzheimer's disease	5.35e-07	2.45e-06	CbGpPWpGaD
Bosutinib—ABL1—Immune System—IL6—Alzheimer's disease	5.34e-07	2.45e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—MAPK8—Alzheimer's disease	5.32e-07	2.44e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by GPCR—AKT1—Alzheimer's disease	5.3e-07	2.43e-06	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—IL6—Alzheimer's disease	5.3e-07	2.43e-06	CbGpPWpGaD
Bosutinib—FYN—Immune System—IL6—Alzheimer's disease	5.28e-07	2.42e-06	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—AKT1—Alzheimer's disease	5.26e-07	2.42e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—ENO1—Alzheimer's disease	5.25e-07	2.41e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	5.25e-07	2.41e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—IL6—Alzheimer's disease	5.25e-07	2.41e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—VEGFA—Alzheimer's disease	5.25e-07	2.41e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—IL6—Alzheimer's disease	5.18e-07	2.38e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—AKT1—Alzheimer's disease	5.18e-07	2.38e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	5.15e-07	2.37e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—TP53—Alzheimer's disease	5.15e-07	2.37e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—MTHFR—Alzheimer's disease	5.12e-07	2.35e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—VEGFA—Alzheimer's disease	5.12e-07	2.35e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—TP53—Alzheimer's disease	5.08e-07	2.33e-06	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—AKT1—Alzheimer's disease	5.07e-07	2.33e-06	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—AKT1—Alzheimer's disease	5.07e-07	2.33e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—IL6—Alzheimer's disease	5.06e-07	2.32e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—AKT1—Alzheimer's disease	5.05e-07	2.32e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—NOS3—Alzheimer's disease	5.05e-07	2.32e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—CASP3—Alzheimer's disease	5.03e-07	2.31e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—VEGFA—Alzheimer's disease	5.01e-07	2.3e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—IL6—Alzheimer's disease	4.99e-07	2.29e-06	CbGpPWpGaD
Bosutinib—LYN—Immune System—AKT1—Alzheimer's disease	4.95e-07	2.27e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—VEGFA—Alzheimer's disease	4.94e-07	2.27e-06	CbGpPWpGaD
Bosutinib—ABL1—Immune System—AKT1—Alzheimer's disease	4.93e-07	2.26e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—VEGFA—Alzheimer's disease	4.91e-07	2.25e-06	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—AKT1—Alzheimer's disease	4.89e-07	2.24e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—BCHE—Alzheimer's disease	4.89e-07	2.24e-06	CbGpPWpGaD
Bosutinib—FYN—Disease—IL6—Alzheimer's disease	4.88e-07	2.24e-06	CbGpPWpGaD
Bosutinib—FYN—Immune System—AKT1—Alzheimer's disease	4.87e-07	2.24e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—IL6—Alzheimer's disease	4.85e-07	2.23e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—AKT1—Alzheimer's disease	4.85e-07	2.22e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—CASP3—Alzheimer's disease	4.84e-07	2.22e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—TP53—Alzheimer's disease	4.82e-07	2.21e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—TGFB1—Alzheimer's disease	4.82e-07	2.21e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—CALM1—Alzheimer's disease	4.79e-07	2.2e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—AKT1—Alzheimer's disease	4.78e-07	2.2e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—APOE—Alzheimer's disease	4.77e-07	2.19e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—TGFB1—Alzheimer's disease	4.77e-07	2.19e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—CAV1—Alzheimer's disease	4.73e-07	2.17e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—IL6—Alzheimer's disease	4.72e-07	2.16e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—TGFB1—Alzheimer's disease	4.7e-07	2.16e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—AKT1—Alzheimer's disease	4.67e-07	2.14e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—IL6—Alzheimer's disease	4.65e-07	2.13e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—MAPK8—Alzheimer's disease	4.62e-07	2.12e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	4.61e-07	2.12e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—AKT1—Alzheimer's disease	4.61e-07	2.11e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—TGFB1—Alzheimer's disease	4.6e-07	2.11e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—IL6—Alzheimer's disease	4.56e-07	2.09e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—TP53—Alzheimer's disease	4.54e-07	2.08e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—TGFB1—Alzheimer's disease	4.53e-07	2.08e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—TGFB1—Alzheimer's disease	4.51e-07	2.07e-06	CbGpPWpGaD
Bosutinib—FYN—Disease—AKT1—Alzheimer's disease	4.5e-07	2.06e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—AKT1—Alzheimer's disease	4.47e-07	2.05e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	4.47e-07	2.05e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—MAPK8—Alzheimer's disease	4.45e-07	2.04e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—IL6—Alzheimer's disease	4.41e-07	2.02e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—IL6—Alzheimer's disease	4.4e-07	2.02e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—AKT1—Alzheimer's disease	4.35e-07	2e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—AKT1—Alzheimer's disease	4.29e-07	1.97e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CASP3—Alzheimer's disease	4.29e-07	1.97e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—VEGFA—Alzheimer's disease	4.27e-07	1.96e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—IL6—Alzheimer's disease	4.21e-07	1.93e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—AKT1—Alzheimer's disease	4.21e-07	1.93e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—PPARG—Alzheimer's disease	4.15e-07	1.91e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—IL6—Alzheimer's disease	4.15e-07	1.91e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—VEGFA—Alzheimer's disease	4.11e-07	1.89e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—INS—Alzheimer's disease	4.08e-07	1.87e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—AKT1—Alzheimer's disease	4.07e-07	1.87e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—IL6—Alzheimer's disease	4.06e-07	1.86e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—AKT1—Alzheimer's disease	4.06e-07	1.86e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—TP53—Alzheimer's disease	3.97e-07	1.82e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—MAPK8—Alzheimer's disease	3.94e-07	1.81e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—TGFB1—Alzheimer's disease	3.91e-07	1.8e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—IL6—Alzheimer's disease	3.89e-07	1.79e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—AKT1—Alzheimer's disease	3.89e-07	1.78e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—TP53—Alzheimer's disease	3.87e-07	1.78e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	3.85e-07	1.77e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	3.83e-07	1.76e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—AKT1—Alzheimer's disease	3.83e-07	1.76e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—TP53—Alzheimer's disease	3.79e-07	1.74e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—TGFB1—Alzheimer's disease	3.77e-07	1.73e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—AKT1—Alzheimer's disease	3.75e-07	1.72e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—TP53—Alzheimer's disease	3.73e-07	1.71e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—TP53—Alzheimer's disease	3.71e-07	1.7e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—VEGFA—Alzheimer's disease	3.64e-07	1.67e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—IL6—Alzheimer's disease	3.63e-07	1.67e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—IL6—Alzheimer's disease	3.59e-07	1.65e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—AKT1—Alzheimer's disease	3.59e-07	1.65e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—NOS3—Alzheimer's disease	3.57e-07	1.64e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—IL6—Alzheimer's disease	3.54e-07	1.63e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—LPL—Alzheimer's disease	3.51e-07	1.61e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—IL6—Alzheimer's disease	3.47e-07	1.59e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—IL6—Alzheimer's disease	3.41e-07	1.57e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—IL6—Alzheimer's disease	3.4e-07	1.56e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—AKT1—Alzheimer's disease	3.35e-07	1.54e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—TGFB1—Alzheimer's disease	3.34e-07	1.53e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—AKT1—Alzheimer's disease	3.32e-07	1.52e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—PTGS2—Alzheimer's disease	3.27e-07	1.5e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—AKT1—Alzheimer's disease	3.27e-07	1.5e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—TP53—Alzheimer's disease	3.22e-07	1.48e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—AKT1—Alzheimer's disease	3.2e-07	1.47e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	3.16e-07	1.45e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—AKT1—Alzheimer's disease	3.15e-07	1.45e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—AKT1—Alzheimer's disease	3.13e-07	1.44e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—TP53—Alzheimer's disease	3.11e-07	1.43e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—IL6—Alzheimer's disease	2.95e-07	1.35e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CALM1—Alzheimer's disease	2.95e-07	1.35e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—APOE—Alzheimer's disease	2.94e-07	1.35e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CAV1—Alzheimer's disease	2.91e-07	1.34e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—IL6—Alzheimer's disease	2.84e-07	1.3e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—TP53—Alzheimer's disease	2.75e-07	1.26e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—AKT1—Alzheimer's disease	2.72e-07	1.25e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—AKT1—Alzheimer's disease	2.62e-07	1.2e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—PPARG—Alzheimer's disease	2.56e-07	1.17e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—IL6—Alzheimer's disease	2.52e-07	1.16e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—INS—Alzheimer's disease	2.51e-07	1.15e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—AKT1—Alzheimer's disease	2.32e-07	1.07e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—NOS3—Alzheimer's disease	2.2e-07	1.01e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	2.01e-07	9.24e-07	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—AKT1—Alzheimer's disease	1.64e-07	7.54e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—AKT1—Alzheimer's disease	1.01e-07	4.65e-07	CbGpPWpGaD
